![Deletion of Apoptosis Inhibitor F1L in Vaccinia Virus Increases Safety and Oncolysis for Cancer Therapy: Molecular Therapy - Oncolytics Deletion of Apoptosis Inhibitor F1L in Vaccinia Virus Increases Safety and Oncolysis for Cancer Therapy: Molecular Therapy - Oncolytics](https://www.cell.com/cms/asset/83e22d00-5767-4c49-b563-ebc92ece8a92/gr1.jpg)
Deletion of Apoptosis Inhibitor F1L in Vaccinia Virus Increases Safety and Oncolysis for Cancer Therapy: Molecular Therapy - Oncolytics
![Cureus | Immunohistochemical Evaluation of S100, Alpha-Smooth Muscle Actin, Podoplanin, Matrix Metalloproteinase 13, and Human Epidermal Growth Factor Receptor 2neu Markers in Basal Cell Carcinoma Variants Cureus | Immunohistochemical Evaluation of S100, Alpha-Smooth Muscle Actin, Podoplanin, Matrix Metalloproteinase 13, and Human Epidermal Growth Factor Receptor 2neu Markers in Basal Cell Carcinoma Variants](https://assets.cureus.com/uploads/figure/file/485383/lightbox_f2afbaa053f111ed8f08a11c5574e6e1-Figure-1.png)
Cureus | Immunohistochemical Evaluation of S100, Alpha-Smooth Muscle Actin, Podoplanin, Matrix Metalloproteinase 13, and Human Epidermal Growth Factor Receptor 2neu Markers in Basal Cell Carcinoma Variants
![PLA1A expression as a diagnostic marker of BRAF-mutant metastasis in melanoma cancer | Scientific Reports PLA1A expression as a diagnostic marker of BRAF-mutant metastasis in melanoma cancer | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-021-85595-7/MediaObjects/41598_2021_85595_Fig1_HTML.png)
PLA1A expression as a diagnostic marker of BRAF-mutant metastasis in melanoma cancer | Scientific Reports
Immunohistochemical Evaluation of S100, Alpha- Smooth Muscle Actin, Podoplanin, Matrix Metalloproteinase 13, and Human Epidermal
![Histopathology and immunostaining for the Schwann cell marker S-100... | Download Scientific Diagram Histopathology and immunostaining for the Schwann cell marker S-100... | Download Scientific Diagram](https://www.researchgate.net/publication/11057837/figure/fig4/AS:646094585360385@1531052361763/Histopathology-and-immunostaining-for-the-Schwann-cell-marker-S-100-protein-of-the-tumor_Q320.jpg)
Histopathology and immunostaining for the Schwann cell marker S-100... | Download Scientific Diagram
![Large-scale proteomic identification of S100 proteins in breast cancer tissues | BMC Cancer | Full Text Large-scale proteomic identification of S100 proteins in breast cancer tissues | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2407-10-476/MediaObjects/12885_2010_Article_2275_Fig5_HTML.jpg)
Large-scale proteomic identification of S100 proteins in breast cancer tissues | BMC Cancer | Full Text
![Frontiers | A Computed Tomography Nomogram for Assessing the Malignancy Risk of Focal Liver Lesions in Patients With Cirrhosis: A Preliminary Study Frontiers | A Computed Tomography Nomogram for Assessing the Malignancy Risk of Focal Liver Lesions in Patients With Cirrhosis: A Preliminary Study](https://www.frontiersin.org/files/MyHome%20Article%20Library/681489/681489_Thumb_400.jpg)
Frontiers | A Computed Tomography Nomogram for Assessing the Malignancy Risk of Focal Liver Lesions in Patients With Cirrhosis: A Preliminary Study
![The Modulatory Role of MicroRNA-873 in the Progression of KRAS-Driven Cancers: Molecular Therapy - Nucleic Acids The Modulatory Role of MicroRNA-873 in the Progression of KRAS-Driven Cancers: Molecular Therapy - Nucleic Acids](https://www.cell.com/cms/asset/fb56cc17-6bb5-457a-986f-bb7f740f3d75/gr1.jpg)
The Modulatory Role of MicroRNA-873 in the Progression of KRAS-Driven Cancers: Molecular Therapy - Nucleic Acids
Cancer of unknown primary: Ancillary testing of cytologic and small biopsy specimens in the era of targeted therapy
![Cancers | Free Full-Text | NR2F1, a Tumor Dormancy Marker, Is Expressed Predominantly in Cancer-Associated Fibroblasts and Is Associated with Suppressed Breast Cancer Cell Proliferation Cancers | Free Full-Text | NR2F1, a Tumor Dormancy Marker, Is Expressed Predominantly in Cancer-Associated Fibroblasts and Is Associated with Suppressed Breast Cancer Cell Proliferation](https://pub.mdpi-res.com/cancers/cancers-14-02962/article_deploy/html/images/cancers-14-02962-g001-550.jpg?1655357259)
Cancers | Free Full-Text | NR2F1, a Tumor Dormancy Marker, Is Expressed Predominantly in Cancer-Associated Fibroblasts and Is Associated with Suppressed Breast Cancer Cell Proliferation
![A) Immunohistochemical detection of the human melanoma markers S-100... | Download Scientific Diagram A) Immunohistochemical detection of the human melanoma markers S-100... | Download Scientific Diagram](https://www.researchgate.net/publication/5428089/figure/fig1/AS:551123356717056@1508409455386/A-Immunohistochemical-detection-of-the-human-melanoma-markers-S-100-and-HMB45-in.png)
A) Immunohistochemical detection of the human melanoma markers S-100... | Download Scientific Diagram
![IJMS | Free Full-Text | Immunological Markers, Prognostic Factors and Challenges Following Curative Treatments for Hepatocellular Carcinoma IJMS | Free Full-Text | Immunological Markers, Prognostic Factors and Challenges Following Curative Treatments for Hepatocellular Carcinoma](https://pub.mdpi-res.com/ijms/ijms-22-10271/article_deploy/html/images/ijms-22-10271-g001.png?1632469653)